Sale by Mcneill Jonathan of 1000 shares of Dyne TherapeuticsInc
DYN Stock | USD 25.61 1.86 6.77% |
About 68% of Dyne Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Dyne Therapeutics suggests that many traders are alarmed. Dyne Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Dyne Therapeutics. Many technical investors use Dyne Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Dyne |
Filed transaction by Dyne Therapeutics Inc officer. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Dyne Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Dyne Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Dyne Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Dyne Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Dyne Therapeutics Fundamental Analysis
We analyze Dyne Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dyne Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dyne Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Dyne Therapeutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Dyne Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dyne Therapeutics stock to make a market-neutral strategy. Peer analysis of Dyne Therapeutics could also be used in its relative valuation, which is a method of valuing Dyne Therapeutics by comparing valuation metrics with similar companies.
Peers
Dyne Therapeutics Related Equities
CYTK | Cytokinetics | 0.91 |
| ||
PLRX | Pliant Therapeutics | 2.46 |
| ||
CGEM | Cullinan Oncology | 2.56 |
| ||
RVMD | Revolution Medicines | 3.23 |
| ||
STOK | Stoke Therapeutics | 5.08 |
| ||
ERAS | Erasca | 5.40 |
| ||
EWTX | Edgewise Therapeutics | 5.54 |
| ||
MLYS | Mineralys Therapeutics, | 6.02 |
| ||
GLUE | Monte Rosa | 8.46 |
| ||
DSGN | Design Therapeutics | 11.01 |
|
Check out Dyne Therapeutics Hype Analysis, Dyne Therapeutics Correlation and Dyne Therapeutics Performance. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.58) | Return On Assets (0.40) | Return On Equity (0.69) |
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.